Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Incyte Corporation - Common Stock (NQ:INCY)

60.97 -1.49 (-2.39%)
Streaming Delayed Price Updated: 2:55 PM EDT, Apr 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,671,066
Open 62.65
Bid (Size) 57.33 (1)
Ask (Size) 64.00 (1)
Prev. Close 62.46
Today's Range 60.67 - 63.57
52wk Range 50.35 - 83.95
Shares Outstanding 222,430,635
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Meta, AMD, Apple, AT&T Among Biggest US Tech Giants That 'May Suffer The Most' As Tariffs Spark Trade Turmoil: Here's Why
Tariffs could heavily impact top tech beneficiaries of globalization as the cost of the goods sold by these firms may rise. 
Via Benzinga
3 Reasons INCY is Risky and 1 Stock to Buy Instead
Over the past six months, Incyte’s shares (currently trading at $60.02) have posted a disappointing 11.8% loss while the S&P 500 was down 1.7%. This was partly driven by its softer quarterly results... 
Via StockStory
Topics Stocks
Exposures US Equities

Performance

YTD
-12.3%
-12.3%
1 Month
-12.7%
-12.7%
3 Month
-12.4%
-12.4%
6 Month
-9.7%
-9.7%
1 Year
+10.9%
+10.9%

More News

Read More
XPeng, Reddit And Micron Tech Are Among Top 10 Large-Cap Losers Last Week (Mar 17-Mar 21): Are The Others In Your Portfolio?
Via Benzinga
Incyte Stock: A Deep Dive Into Analyst Perspectives (6 Ratings)
Via Benzinga
What's going on in today's session: S&P500 movers
Via Chartmill
Why Incyte Stock Was Tanking This Week
Via The Motley Fool
1 Healthcare Stock on Our Watchlist and 2 to Brush Off
Via StockStory
Topics Stocks
Exposures COVID-19 US Equities
Natera (NASDAQ:NTRA) Q4 Earnings: Leading The Immuno-Oncology Pack
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
Tesla To $320? Here Are 10 Top Analyst Forecasts For Tuesday
Via Benzinga
This PepsiCo Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
Via Benzinga
What's going on in today's after hours session: S&P500 movers
Via Chartmill
Stay informed with the top movers within the S&P500 index on Monday.
Via Chartmill
Uncover the latest developments among S&P500 stocks in today's session.
Via Chartmill
Why Incyte (INCY) Stock Is Nosediving
Via StockStory
Gapping S&P500 stocks in Monday's session
Via Chartmill
These S&P500 stocks are moving in today's pre-market session
Via Chartmill
Which stocks are moving before the opening bell on Monday?
Via Chartmill
Incyte's New Treatment for Chronic Skin Disease Shows Promising Results In Latest Clinical Trials, Stock Falls
Via Benzinga
Incyte Plummets 13% As Skin Disease Drug Looks 'Viable, But Not Competitive'
Via Investor's Business Daily
Incyte, Tesla And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Via Benzinga
Don't overlook INCYTE CORP (NASDAQ:INCY)—it's a hidden gem with strong fundamentals and an attractive price tag.
Via Chartmill
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Why Precision BioSciences Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Incyte Announces Positive Topline Results From Two Phase 3 Clinical Trials of Povorcitinib in Patients With Hidradenitis Suppurativa
From Incyte
Via Business Wire
Eli Lilly-Incyte Partnered FDA-Approved Drug Shows Encouraging Efficacy In Adolescent Patients With Patchy Hair Loss
Via Benzinga

Frequently Asked Questions

Is Incyte Corporation - Common Stock publicly traded?
Yes, Incyte Corporation - Common Stock is publicly traded.
What exchange does Incyte Corporation - Common Stock trade on?
Incyte Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Incyte Corporation - Common Stock?
The ticker symbol for Incyte Corporation - Common Stock is INCY on the Nasdaq Stock Market
What is the current price of Incyte Corporation - Common Stock?
The current price of Incyte Corporation - Common Stock is 60.97
When was Incyte Corporation - Common Stock last traded?
The last trade of Incyte Corporation - Common Stock was at 04/04/25 02:55 PM ET
What is the market capitalization of Incyte Corporation - Common Stock?
The market capitalization of Incyte Corporation - Common Stock is 13.56B
How many shares of Incyte Corporation - Common Stock are outstanding?
Incyte Corporation - Common Stock has 14B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.